董事
Raymond W. Cohen is a veteran medical technology executive with over 40 years of experience in the life sciences industry, currently serving as an independent director on the board of Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), where he has recently engaged in insider trading activities[[1]](https://www.businesswire.com/news/home/20240725221367/en/Kestra-Medical-Technologies-Announces-Appointment-of-Veteran-Medical-Device-Executive-Raymond-W.-Cohen-to-its-Board-of-Directors)[[2]](https://inspiremd.com/team/raymond-w-cohen/)[[4]](https://nalumed.com/nalu-medical-appoints-veteran-medtech-executive-raymond-w-cohen-chairman-of-its-board-of-directors/). He joined Kestra's board in 2024, bringing expertise in external defibrillation and commercial growth strategies to support the company's ASSURE Wearable Cardioverter Defibrillator[[1]](https://www.businesswire.com/news/home/20240725221367/en/Kestra-Medical-Technologies-Announces-Appointment-of-Veteran-Medical-Device-Executive-Raymond-W.-Cohen-to-its-Board-of-Directors). Cohen holds board positions at multiple medtech firms, including InspireMD, Spectrum Vascular, Nalu Medical (as Chairman), Tulavi (as Vice Chairman), and others[[2]](https://inspiremd.com/team/raymond-w-cohen/)[[3]](https://west.devicetalks.com/speaker/raymond-cohen/)[[4]](https://nalumed.com/nalu-medical-appoints-veteran-medtech-executive-raymond-w-cohen-chairman-of-its-board-of-directors/)[[6]](https://www.bio-beat.com/member/raymond-w-cohen/).
Cohen co-founded Axonics, Inc. in 2013, served as CEO, took it public in 2018, and led it to a $3.7 billion acquisition by Boston Scientific in 2024, earning recognitions such as Deloitte Technology Fast 500 top ranking and Financial Times' fastest-growing company in the Americas[[1]](https://www.businesswire.com/news/home/20240725221367/en/Kestra-Medical-Technologies-Announces-Appointment-of-Veteran-Medical-Device-Executive-Raymond-W.-Cohen-to-its-Board-of-Directors)[[2]](https://inspiremd.com/team/raymond-w-cohen/)[[3]](https://west.devicetalks.com/speaker/raymond-cohen/)[[4]](https://nalumed.com/nalu-medical-appoints-veteran-medtech-executive-raymond-w-cohen-chairman-of-its-board-of-directors/). Previously, he was CEO of Vessix Vascular (acquired by Boston Scientific in 2012) and Cardiac Science Inc. (acquired by Zoll Medical), and Chairman of SoniVie Ltd. (acquired by Boston Scientific for $600 million in 2025)[[2]](https://inspiremd.com/team/raymond-w-cohen/)[[3]](https://west.devicetalks.com/speaker/raymond-cohen/)[[4]](https://nalumed.com/nalu-medical-appoints-veteran-medtech-executive-raymond-w-cohen-chairman-of-its-board-of-directors/). Awards include the 2024 MedTech MVP Award, Orange County Business Journal Businessperson of the Year, SoCalBio Lifetime Achievement Award (2021), and Ernst & Young Entrepreneur of the Year (2020)[[1]](https://www.businesswire.com/news/home/20240725221367/en/Kestra-Medical-Technologies-Announces-Appointment-of-Veteran-Medical-Device-Executive-Raymond-W.-Cohen-to-its-Board-of-Directors)[[3]](https://west.devicetalks.com/speaker/raymond-cohen/)[[4]](https://nalumed.com/nalu-medical-appoints-veteran-medtech-executive-raymond-w-cohen-chairman-of-its-board-of-directors/). He holds a B.S. in Business Management from Binghamton University[[3]](https://west.devicetalks.com/speaker/raymond-cohen/).
查看完整内部人档案 →